1. microRNA‐26a‐5p affects myocardial injury induced by coronary microembolization by modulating HMGA1
   Binghui Kong et al, 2019, Journal of Cellular Biochemistry CrossRef
2. MiR-21, MiR-29a, GATA4, and MEF2c Expression Changes in Endothelin-1 and Angiotensin II Cardiac Hypertrophy Stimulated Isl-1+Sca-1+c-kit+ Porcine Cardiac Progenitor Cells In Vitro
   Katrin Zlabinger et al, 2019, Cells CrossRef
3. Microtubule associated protein 4 phosphorylation leads to pathological cardiac remodeling in mice
   Lingfei Li et al, 2018, EBioMedicine CrossRef
4. Molecular Mechanisms of Action of Emodin: As an Anti-Cardiovascular Disease Drug
   Qianqian Li et al, 2020, Frontiers in Pharmacology CrossRef
5. The Impact of microRNAs in Renin–Angiotensin-System-Induced Cardiac Remodelling
   Michaela Adamcova et al, 2021, International Journal of Molecular Sciences CrossRef
6. Differential Spatio-Temporal Regulation of T-Box Gene Expression by microRNAs during Cardiac Development
   Mohamad Alzein et al, 2021, Journal of Cardiovascular Development and Disease CrossRef
7. New Insights and Current Approaches in Cardiac Hypertrophy Cell Culture, Tissue Engineering Models, and Novel Pathways Involving Non-Coding RNA
   Nina Kastner et al, 2020, Frontiers in Pharmacology CrossRef
8. Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4
   Hui Li et al, 2020, Cardiovascular Research CrossRef
9. The Role and Molecular Mechanism of Non-Coding RNAs in Pathological Cardiac Remodeling
   Jinning Gao et al, 2017, International Journal of Molecular Sciences CrossRef
10. Retracted: Emodin protects H9c2 cells against hypoxia‐induced injury via regulation of miR‐26a/survivin and the JAK1/STAT3 pathway
    Jiancheng Huang et al, 2019, Journal of Cellular Biochemistry CrossRef
11. MicroRNA-322-5p targeting Smurf2 regulates the TGF-β/Smad pathway to protect cardiac function and inhibit myocardial infarction
    Liping Guo et al, 2024, Human Cell CrossRef
12. LncRNA 2810403D21Rik/Mirf promotes ischemic myocardial injury by regulating autophagy through targeting Mir26a
    Haihai Liang et al, 2020, Autophagy CrossRef
13. Characterization and analysis of long non-coding rna (lncRNA) in In Vitro- and Ex Vivo-derived cardiac progenitor cells
    Baron Arnone et al, 2017, PLOS ONE CrossRef
14. DEC1 represses cardiomyocyte hypertrophy by recruiting PRP19 as an E3 ligase to promote ubiquitination-proteasome-mediated degradation of GATA4
    Lin Cheng et al, 2022, Journal of Molecular and Cellular Cardiology CrossRef
15. MiR-26a enhances invasive capacity by suppressing GSK3β in human lung cancer cells
    Gaoyang Lin et al, 2017, Experimental Cell Research CrossRef
16. Non-coding RNAs in Cardiomyopathy and Heart Failure
    Paul Holvoet, 2021, Non-coding RNAs at the Cross-Road of Cardiometabolic Diseases and Cancer CrossRef
17. Uso de micro RNA en el manejo de la insuficiencia cardiaca
    Luis Alejandro Arias Sosa, 2017, Archivos de Cardiología de México CrossRef
18. Downregulation of miR-200c protects cardiomyocytes from hypoxia-induced apoptosis by targeting GATA-4
    Zhigang Chen et al, 2017, International Journal of Molecular Medicine CrossRef
19. Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
    Steven J. Forrester et al, 2018, Physiological Reviews CrossRef
20. MicroRNAs—The Heart of Post-Myocardial Infarction Remodeling
    Liana Maries et al, 2021, Diagnostics CrossRef
21. Autophagy Regulation by Crosstalk between miRNAs and Ubiquitination System
    Junyan Qu et al, 2021, International Journal of Molecular Sciences CrossRef
22. MiR‐26a‐5p alleviates cardiac hypertrophy and dysfunction via targeting ADAM17
    Hongtao Shi et al, 2021, Cell Biology International CrossRef